Erytech Pharma confirms strategic focus of eryaspase on solid tumors
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Erytech Pharma (ERYP) Confirms Strategic Focus Of Eryaspase On Solid Tumors And Ceases Development In Acute Lymphoblastic Leukemia - Slideshow
Erytech Pharma (ERYP) Confirms Strategic Focus Of Eryaspase On Solid Tumors And Ceases Development In Acute Lymphoblastic Leukemia - Slideshow.....»»
ERYTECH Reports First Half of 2018 Financial Results and Provides Business Update
Conference call and webcast scheduled for Tuesday, September 11that 2:30 pm CET/8:30 am EDT Strategic shift to development of eryaspase for solid tumors confirmed Phase 3 trial for eryaspase in second line pan.....»»
Erytech Pharma initiates process to seek FDA approval for eryaspase
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Erytech Pharma completes enrollment for first cohort of eryaspase trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Erytech Pharma granted FDA fast track designation for eryaspase
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Novo Nordisk: A Rare Case of Pharma With Balanced Risk and Reward
A strategic focus, dominant positions and secular growth opportunities outweigh the general pipeline riskRelated Stocks: OCSE:NOVOB, NVO, LLY, LSE:AZN, XSWX:NOVN,.....»»
Erytech Pharma announces publication of eryaspase Phase 2b trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
ImmunoGen To Focus Operations On Mivetuximab Soravtansine Development
ImmunoGen (NASDAQ: IMGN) focuses on antibody-drug conjugates for the treatment of cancer and the company said Thursday it will prioritize continued development of “Mivetuximab Soravtansine†targeting solid tumors read more.....»»
Erytech Pharma announces strategic collaboration with SQZ Biotechnologies
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Erytech Pharma announces FDA acceptance of eryaspase IND application
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Erytech Pharma to present data from Phase 2/3 trial of eryaspase at ASCO
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Flex Pharma to focus resources on assessing strategic alternatives
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Perrigo plans to separate prescription pharma business
Perrigo Co Plc said on Thursday it would separate its generics prescription business, which has been a drag on results, to focus on consumer healthcare following a strategic review, sending the drugmaker's shares down about 8 percent......»»
Community Foundation of Greater Birmingham awards $1.52M in grants
The Birmingham organization awarded the funds with a new strategic focus in mind......»»
Aveanna initiated with a Buy at Truist on solid strategic positioning
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Micro Focus announces expanded strategic collaboration with Microsoft
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Element Reports First Quarter Results Reflecting Solid Progress in Advancing Strategic Priorities
Amounts in $CAD unless otherwise noted Q1 adjusted operating income of $137.3 million was a 6.2% increase over Q1 2020 and equivalent to $0.22 on a per share basis Through strong .....»»
LogicBio Therapeutics announces strategic collaboration with CANbridge Pharma
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Zosano Pharma confirms plans to proceed with PK study after FDA protocol review
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Royalty Pharma, MSCI enters strategic alliance for life science indexes
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»